Roche drug gets provisional tick

By Megan Brodie 3 years ago | In Companies, Products, Vaccines
  • 3 years ago
Roche's Actemra (tocilizumab) is in severe shortage globally (istock.com/Teka77)

29 September 2021 The TGA has given Roche a provisional determination for its rheumatoid arthritis…

This is subscriber-only content. Please login to continue reading.